At a glance
ClinicalIndex Comparison RecordN/ACompleted· 590 enrolled
Drug / intervention
Continuous renal replacement therapy with oXirisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multiple Centre, Cohort Study of New Continuous Renal Replacement Therapy (CRRT) Membranes oXiris for Patients With Septic Shock
In Brief
An observational study evaluating Continuous renal replacement therapy with oXiris for Acute Kidney Injury Due to Sepsis (Disorder). Completed, enrolled 590 participants across 2 sites.
Detailed Summary
The objectives of this study are to determine whether Continuous Renal Replacement Therapy (CRRT) with oXiris in patients with septic shock would improve clinical outcomes such as the sepsis-related organ failure assessment (SOFA) , hemodynamic, mortality compared CRRT with conventional membrane.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
CollaboratorsBaxter Healthcare Corporation
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedAug 2019
Enrollment StartSep 2019
Primary CompletionJun 2021
Study CompletionOct 2021
TodayJul 2026
First PostedAug 29, 2019
Enrollment StartSep 21, 2019
Primary CompletionJun 30, 2021
Study CompletionOct 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.8 years ago
Interventions
Continuous renal replacement therapy with oXirisdevice
Continuous renal replacement therapy with oXiris in patient with septic shock